-
Japanese University Will Research Marijuana's Medical Uses In First-Of-Its-Kind Collaboration With Australian Company
Wednesday, January 31, 2024 - 12:50pm | 493An Australian, vertically integrated plant-based medicine company, Cannatrek, will collaborate with a Japanese University to empower research on medical marijuana. What happened: Cannatrek reported Tuesday it has signed a Memorandum of Understanding (Mou) with Mie University in Tsu, Japan, to...
-
Organigram Q4 Revenue Grows 83% YoY, Provides Outlook
Tuesday, November 29, 2022 - 8:49am | 815Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) released its results for the fourth quarter and year ended August 31, 2022, revealing net revenue in FY 2022 increased 84% to $145.8 million from $79.2 million in the previous year primarily due to an increase in recreational and international...
-
Children's Palliative Care & Medical Cannabis: Australian Researchers Conduct Pilot Study
Friday, October 14, 2022 - 9:54am | 430A new study is underway to investigate how medical cannabis can help reduce symptoms in children and adolescents with non-cancerous conditions, reported EurekAlert. Palliative Care: Essential for those with serious illnesses. The pilot study conducted at Australia's...
-
Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower
Monday, February 14, 2022 - 10:15am | 370Clever Leaves Holdings Inc. (NASDAQ: CLVR) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement. The deal includes high-THC flower from Portugal, while expanding on its existing partnership for...